Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
Rachel MataPublished in: ACS medicinal chemistry letters (2023)
Provided herein are novel pyrazoloquinoline compounds as KRAS inhibitors, their pharmaceutical compositions, the use of such compounds in treating cancer, and processes for preparing such compounds.